Emergent BioSolutions Inc. (NYSE:EBS) Q1 2025 Earnings Call Transcript

Emergent BioSolutions Inc. (NYSE:EBS) Q1 2025 Earnings Call Transcript May 7, 2025

Emergent BioSolutions Inc. beats earnings expectations. Reported EPS is $0.71, expectations were $0.49.

Operator: Good day and thank you for standing by. Welcome to the First Quarter 2025 Emergent BioSolutions, Inc. Earnings Conference Call. [Operator Instructions] Please be advised that today’s conference is being recorded. I would now like to hand the conference over to your speaker today, Frank Vargo,...